Scrutinizing 510(k)s: Critical Voices Get Heard In Congress

Consumer advocacy groups have recently stepped up efforts to publicly scrutinize FDA's 510(k) premarket notification process for devices and push for a higher burden of proof for getting the products to market

More from Archive

More from Medtech Insight